ClariVest Asset Management’s Zimmer Biomet ZBH Stock Holding History

ClariVest Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.71K	Hold	25	–	–	﹤0.01%	493
2024 Q2	$2.71K	Sell	25 -87	-78%	-$10.3K	﹤0.01%	493
2024 Q1	$14.8K	Buy	112 +25	+29%	+$3.12K	﹤0.01%	391
2023 Q4	$10.6K	Hold	87	–	–	﹤0.01%	406
2023 Q3	$9K	Sell	87 -31	-26%	-$3.94K	﹤0.01%	406
2023 Q2	$18K	Buy	118 +62	+111%	+$8.43K	﹤0.01%	371
2023 Q1	$8K	Buy	+56	New	+$7.03K	﹤0.01%	465
2021 Q4	–	Sell	-67,182	Closed	-$9.55M	–	822
2021 Q3	$9.55M	Hold	67,182	–	–	0.31%	72
2021 Q2	$10.5M	Sell	67,182 -3,502	-5%	-$567K	0.35%	61
2021 Q1	$11M	Sell	70,684 -7,622	-10%	-$1.18M	0.39%	58
2020 Q4	$11.7M	Sell	78,306 -11,925	-13%	-$1.68M	0.4%	58
2020 Q3	$11.9M	Sell	90,231 -28,422	-24%	-$3.71M	0.39%	55
2020 Q2	$13.8M	Sell	118,653 -24,263	-17%	-$2.8M	0.38%	60
2020 Q1	$14M	Buy	142,916 +34,876	+32%	+$4.57M	0.42%	55
2019 Q4	$15.7M	Buy	+108,040	New	+$14.9M	0.36%	69

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

ClariVest Asset Management's ZBH Position: Q3 2024 in Review

ClariVest Asset Management held its Zimmer Biomet (ZBH) position steady in Q3 2024 at 25 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

ClariVest Asset Management first reported a position in ZBH in Q4 2019 and has held it in 15 quarters since. The position peaked at $15.7M in Q4 2019. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

ClariVest Asset Management held 25 shares of Zimmer Biomet worth $2.71K as of Q3 2024.
ClariVest Asset Management left its Zimmer Biomet share count unchanged in Q3 2024.
Zimmer Biomet made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #493 holding.
ClariVest Asset Management first reported a position in Zimmer Biomet in Q4 2019 and has held it in 15 quarters since.
ClariVest Asset Management's Zimmer Biomet position peaked at $15.7M in Q4 2019.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.